Neprilysin and Aβ clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer's disease

MOW Grimm, J Mett, CP Stahlmann… - Frontiers in aging …, 2013 - frontiersin.org
One of the characteristic hallmarks of Alzheimer's disease (AD) is an accumulation of
amyloid β (Aβ) leading to plaque formation and toxic oligomeric Aβ complexes. Besides the …

Molecular basis of selective amyloid‐β degrading enzymes in Alzheimer's disease

J Żukowska, SJ Moss, V Subramanian… - The FEBS …, 2024 - Wiley Online Library
The accumulation of the small 42‐residue long peptide amyloid‐β (Aβ) has been proposed
as a major trigger for the development of Alzheimer's disease (AD). Within the brain, the …

Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5′-untranslated region: Implications in Alzheimer's disease

JM Long, B Maloney, JT Rogers, DK Lahiri - Molecular psychiatry, 2019 - nature.com
In addition to the devastating symptoms of dementia, Alzheimer's disease (AD) is
characterized by accumulation of the processing products of the amyloid-β (Aβ) peptide …

[HTML][HTML] Phosphorylation of amyloid beta (Aβ) peptides–A trigger for formation of toxic aggregates in Alzheimer's disease

S Kumar, J Walter - Aging (Albany NY), 2011 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common form of dementia and associated with the
progressive accumulation of amyloid β-peptides (Aβ) in form of extracellular amyloid …

MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced …

JM Long, B Ray, DK Lahiri - Journal of Biological Chemistry, 2014 - ASBMB
Alzheimer disease (AD) results, in part, from the excess accumulation of the amyloid-β (Aβ)
peptide as neuritic plaques in the brain. The short Aβ peptide is derived from the large …

An integrative toxicogenomic analysis of plastic additives

M Sendra, P Pereiro, A Figueras, B Novoa - Journal of Hazardous Materials, 2021 - Elsevier
In developed countries, contact with plastics is constant. Plastics contain a vast number of
additives such as plasticisers, stabilisers, antioxidants, flame retardants, etc., that can impact …

Are amyloid‐degrading enzymes viable therapeutic targets in Alzheimer's disease?

NN Nalivaeva, C Beckett, ND Belyaev… - Journal of …, 2012 - Wiley Online Library
J. Neurochem.(2012) 120 (Suppl. 1), 167–185. Abstract The amyloid cascade hypothesis of
Alzheimer's disease envisages that the initial elevation of amyloid β‐peptide (Aβ) levels …

Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach

NS Soleimani Zakeri, S Pashazadeh, H MotieGhader - Scientific reports, 2020 - nature.com
Alzheimer's disease (AD) is a chronic neurodegenerative disorder. It is the most common
type of dementia that has remained as an incurable disease in the world, which destroys the …

[HTML][HTML] Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive …

KRV Kurapati, VSR Atluri, T Samikkannu, MPN Nair - PLoS One, 2013 - journals.plos.org
Alzheimer's disease (AD) is characterized by progressive dysfunction of memory and higher
cognitive functions with abnormal accumulation of extracellular amyloid plaques and …

BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease

L Chami, F Checler - Molecular neurodegeneration, 2012 - Springer
Alzheimer's disease (AD) is a complex age-related pathology, the etiology of which has not
been firmly delineated. Among various histological stigmata, AD-affected brains display …